Skip to main content

Table 4 Summary of analysis by linear mixed-effects modelling of the time-dependent effects of trientine treatment between Weeks 8 and 16 on indexes of cardiac function in diabetic cardiomyopathy

From: Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment

Variable

Treatment

Week

Treatment:Week

Body-weight (g)

NS

NS

0.035

Blood glucose (mM)

NS

NS

NS

Heart rate (bpm)

0.098

NS

NS

LVM (g)

0.023

NS

0.046

LVM/BW

0.096

0.0057

0.0077

CO (ml/min)

0.0009

NS

< 0.0001

CO/LVM (ml/min.mg)

0.0001

0.0003

< 0.0001

LVEF (%)

< 0.0001

< 0.0001

< 0.0001

LVEDV (μl)

0.018

0.0003

0.0091

LVEDV/LVM (μl/mg)

0.0041

NS

0.0013

LVESV (μl)

0.0013

< 0.0001

< 0.0001

LVESV/LVM (μl/mg)

< 0.0001

< 0.0001

< 0.0001

Stroke Vol (μl)

< 0.0001

0.10

< 0.0001

Stroke Vol/LVM (μl/mg)

< 0.0001

0.0002

< 0.0001

  1. Numbers are P- values derived from the fitting of LME models of the general form (Variable ~ [treatment + week + treatment:week]) for each of the indicated variables, wherein individual rats were considered to generate random effects. Abbreviations: bpm, beats per minute; NS, not significant; Treatment:Week, treatment-week interaction term.